The board authorized the repurchase of an additional $1.5 billion of its common stock. In 2019, Cerner repurchased $1.3 billion of its shares and had $200 million of available authorization remaining prior to the increase announced on Dec. 13. The total authorized amount available for repurchase is now $1.7 billion.
No time limit was set for completion of the program, and Cerner plans to fund its capital allocation program with cash from operations and debt.
Cerner also announced it will pay stockholders a cash dividend of $0.18 per share, which will be payable on Jan. 9, 2020. Cerner plans to continue paying dividends each quarter based on the company’s financial and operational standing as well as cash flows and capital requirements.
More articles on EHRs:
Only 10% of patients access their digital medical records, study finds
CommonWell Health appoints new executive director: 5 things to know
Athenahealth launches interactive flu tracker
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
